Biopharma Week in Review - Jul 8, 2024

316 Views08 Jul 2024 22:03
Issuer-paid
The cost of Kisunla is $32K/year, which is at a premium to Leqembi (Biogen, Inc. [BIIB]/Eisai Co., Ltd. [ESAIY]) at $26.5K/year, but total cost per patient should be lower for Kisunla
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
chart-bar
  • Biopharma Week in Review - Jul 8, 2024
    08 Jul 2024
x